Skip to content

CDR

Merlo: CVS Caremark is in a sweet spot

Merlo: CVS Caremark is in a sweet spot

In today’s complex health care market, CVS Caremark Corp. has the right business model and the right game plan to drive innovation in pharmacy care and spur company growth, president and chief executive officer Larry Merlo said at the annual shareholders meeting here.

More regional drug chains join RxAlly network

More regional drug chains join RxAlly network

Ten regional drug store chains and nine independent pharmacy organizations have joined RxAlly, a national alliance of over 20,000 pharmacies formed earlier this year to stake a bigger claim for community pharmacy in the nation’s health care delivery system.

NACDS, NCPA voice concerns about TRICARE

The National Association of Chain Drug Stores and the National Community Pharmacists Association shared their concerns with Senate and House leaders over the potential impact of the Obama administration’s 2013 budget on TRICARE beneficiaries and community pharmacy.

Done deal: Walgreens closes BioScrip acquisition

Walgreen Co. has wrapped up its acquisition of BioScrip Inc.’s community specialty pharmacies and centralized specialty pharmacy and mail-service pharmacy businesses. BioScrip’s community specialty pharmacy network includes 30 pharmacy locations in 16 states and the District of Columbia.

Walgreens serves up BP testing free

Walgreen Co. is offering free blood pressure testing at all of its drug stores and Take Care Clinics daily during May as part of National High Blood Pressure Education Month and to support the Million Hearts initiative.

Navarro puts store remodel in spotlight

Navarro Discount Pharmacy showcased its remodeled store in Coral Gables, Fla., with a grand opening event attended by company executives and local officials. The Coral Gables store features a new self-serve fragrance counter.

Rite Aid unveils debt refinancing plan

Rite Aid Corp. plans to issue $426 million senior unsecured notes due in 2020 to help fund a refinancing of debt. The drug chain on Thursday began a cash tender offer to buy $405 million of its 9.375% senior notes due in 2015. The company said it would call any of